Next 10 |
home / stock / bblg / bblg articles
BURLINGTON, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ:BBLG, BBLGW)), a dev...
By Brad Sorensen, CFA READ THE FULL BBLG RESEARCH REPORT There are approximately 350,000 spinal fusion surgeries done in the US every year with var...
Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public offering. BioV...
Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update. The compa...
Shares of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) rose sharply in today’s pre-market trading session. Titan Pharmaceuticals said its Boar...
U.S. markets were mixed on the last day of trading in 2023. The Dow Jones and S&P 500 experienced gains, rising by 0.14% and 0.04% respectively...
Bone Biologics Corp (NASDAQ: BBLG) shares are trading higher Thursday and has been halted multiple times despite a lack of company-specific news. H...
Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase pro...
Bone Biologics Corp (NASDAQ: BBLG) shares are trading lower by 12% to $0.54 Monday morning on downward momentum after the company last we...
News, Short Squeeze, Breakout and More Instantly...
Brings 30+ years of commercial experience in the orthopedic and spine industry Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW) , a developer of orthobiologic products for spine fusion markets, announces the appointme...
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW) , a developer of orthobiologic products for spine fusion markets , announces that Jeffrey Frelick, chief executive officer, will present virtually at the H.C. Wainwright 26 th ...